rs56033670
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2
The NM_000096.4(CP):āc.2522C>Gā(p.Thr841Arg) variant causes a missense change. The variant allele was found at a frequency of 0.00504 in 1,588,296 control chromosomes in the GnomAD database, including 36 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ā ). Another nucleotide change resulting in same amino acid change has been previously reported as Likely benignin UniProt.
Frequency
Consequence
NM_000096.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -16 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CP | NM_000096.4 | c.2522C>G | p.Thr841Arg | missense_variant | 14/19 | ENST00000264613.11 | NP_000087.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CP | ENST00000264613.11 | c.2522C>G | p.Thr841Arg | missense_variant | 14/19 | 1 | NM_000096.4 | ENSP00000264613.6 | ||
CP | ENST00000494544.1 | c.1871C>G | p.Thr624Arg | missense_variant | 11/16 | 1 | ENSP00000420545.1 | |||
CP | ENST00000490639.5 | n.2554C>G | non_coding_transcript_exon_variant | 14/17 | 1 | |||||
CP | ENST00000481169.5 | n.2309C>G | non_coding_transcript_exon_variant | 13/18 | 2 | ENSP00000418773.1 |
Frequencies
GnomAD3 genomes AF: 0.00440 AC: 616AN: 139914Hom.: 0 Cov.: 30
GnomAD3 exomes AF: 0.00428 AC: 1076AN: 251424Hom.: 10 AF XY: 0.00417 AC XY: 566AN XY: 135876
GnomAD4 exome AF: 0.00510 AC: 7389AN: 1448308Hom.: 36 Cov.: 35 AF XY: 0.00506 AC XY: 3645AN XY: 720516
GnomAD4 genome AF: 0.00440 AC: 616AN: 139988Hom.: 0 Cov.: 30 AF XY: 0.00401 AC XY: 268AN XY: 66866
ClinVar
Submissions by phenotype
not provided Benign:4
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Aug 01, 2024 | CP: BS2 - |
Likely benign, no assertion criteria provided | clinical testing | Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen | - | - - |
Likely benign, no assertion criteria provided | clinical testing | Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center | - | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Nov 12, 2018 | - - |
not specified Benign:3
Benign, no assertion criteria provided | clinical testing | Genome Diagnostics Laboratory, Amsterdam University Medical Center | - | - - |
Likely benign, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Jan 28, 2016 | - - |
Likely benign, criteria provided, single submitter | clinical testing | Genetic Services Laboratory, University of Chicago | Nov 21, 2019 | - - |
Deficiency of ferroxidase Benign:3
Likely benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 12, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 21, 2024 | - - |
Likely benign, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Nov 03, 2021 | - - |
CP-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Mar 26, 2021 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at